课题基金 / 基金详情

ORAL GI262570X IN PATIENTS W/ TYPE 2 DIABETES MELLITUS

ORAL GI262570X IN PATIENTS W/ TYPE 2 DIABETES MELLITUS
2 型糖尿病患者口服 GI262570X
批准号:
6423263
负责人:
John Bernard Buse
金额:
$29.46万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-12-01 至 2001-11-30

项目成果

John Bernard Buse的其他基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
North Carolina Translational and Clinical Sciences Institute (NC TraCS)
  • 批准号:
    10621596
  • 项目类别:
  • 资助金额:
    $1004.21万
  • 财政年份:
    2023
  • 负责人:
    John Bernard Buse
  • 依托单位:
CTSA Diversity Supplement - Vielot - Effectiveness of Recombinant Herpes Zoster Vaccine in Older U.S. Adults
CAMP FHIR: Lightweight, Open-Source FHIR Conversion Software to Support EHR Data Harmonization and Research
ICEES+ COVID-19 Open Infrastructure to Democratize and Accelerate Cross-Institutional Clinical Data Sharing and Research